Q1 2022 |
14 |
$512M |
+$120M |
-$421M |
-$302M |
VRRM, AMZN, RIVN, FCNCA, FATE
|
13F-HR |
5/16/2022, 12:18 PM |
Q4 2021 |
20 |
$967M |
+$270M |
-$104M |
+$165M |
RIVN, JD, VRRM, PAE, CVNA
|
13F-HR |
2/14/2022, 03:10 PM |
Q3 2021 |
19 |
$784M |
+$84.4M |
-$220M |
-$136M |
JD, VRRM, FATE, PCG, PAE
|
13F-HR |
11/15/2021, 02:12 PM |
Q2 2021 |
21 |
$1.01B |
+$128M |
-$555M |
-$427M |
JD, VRRM, FATE, CVNA, META
|
13F-HR |
8/16/2021, 02:00 PM |
Q1 2021 |
24 |
$1.36B |
+$415M |
-$908M |
-$493M |
AMZN, MSFT, JD, CVNA, FATE
|
13F-HR |
5/17/2021, 03:00 PM |
Q4 2020 |
31 |
$1.84B |
+$447M |
-$363M |
+$84M |
U, FATE, DIS, EXPE, USB
|
13F-HR |
2/16/2021, 02:50 PM |
Q3 2020 |
31 |
$1.36B |
+$410M |
-$222M |
+$187M |
U, DIS, FATE, IQV, HLT
|
13F-HR |
11/13/2020, 01:20 PM |
Q2 2020 |
22 |
$1.07B |
+$175M |
-$188M |
-$13.4M |
NFLX, DIS, FATE, IQV, PAE
|
13F-HR |
8/12/2020, 09:16 PM |
Q1 2020 |
22 |
$880M |
+$417M |
-$35.6M |
+$381M |
NFLX, FIS, IQV, DIS, HLT
|
13F-HR |
5/15/2020, 04:16 PM |
Q4 2019 |
15 |
$600M |
+$68.4M |
-$96.1M |
-$27.7M |
HLT, IQV, NFLX, FI, VRRM
|
13F-HR |
2/12/2020, 05:23 PM |
Q3 2019 |
19 |
$553M |
+$222M |
-$68.4M |
+$154M |
HLT, IQV, FI, DIS, NFLX
|
13F-HR |
11/14/2019, 04:15 PM |
Q2 2019 |
16 |
$427M |
+$125M |
-$49.1M |
+$76.4M |
HLT, IQV, NFLX, DIS, CCK
|
13F-HR |
8/14/2019, 04:30 PM |
Q1 2019 |
15 |
$351M |
+$71.3M |
-$94M |
-$22.7M |
HLT, IQV, VRRM, CCK, OMF
|
13F-HR |
5/15/2019, 04:30 PM |
Q4 2018 |
14 |
$335M |
+$199M |
-$142M |
+$57.8M |
HLT, OMF, NFLX, VRRM, ROAN
|
13F-HR |
2/14/2019, 02:30 PM |
Q3 2018 |
13 |
$322M |
+$32.1M |
-$180M |
-$148M |
OMF, VIAB, LAUR, LUV, DAL
|
13F-HR |
11/14/2018, 03:01 PM |
Q2 2018 |
16 |
$435M |
$0 |
$0 |
|
OMF, NXPI, LAUR, VIAB, UAL
|
13F-HR |
8/14/2018, 04:18 PM |